Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 78

Sort by

Sort Order Select

Journal Articles

Uncertainty in the R2 Calibration Curve for High Iron Concentration

John C Wood, MD PhD, Eamon Doyle, PhD, Nilesh Ghugre, PhD, Thomas Coates, MD

Blood (2019) 134 (Supplement_1): 3541.

https://doi.org/10.1182/blood-2019-128886

Published: 2019

Journal Articles

Estimation of the Economic Burden Associated with Major Surgery Due to Von Willebrand Disease Based on Claims Data from the USA

Abiola Oladapo, Yanyu Wu, Mei Lu, Sepehr Farahbakhshian, Bruce Ewenstein

Blood (2019) 134 (Supplement_1): 4692.

https://doi.org/10.1182/blood-2019-122749

Published: 2019

Journal Articles

Validation of the Ottawa Score in Cancer Patients with Venous Thromboembolism. the Predicare Cohort Study

Guy Meyer, Celine Chapelle, Philippe Girard, MD, Florian Scotté, MD PhD, Anne Lamblin, Silvy Laporte, MS, PhD

Blood (2019) 134 (Supplement_1): 167.

https://doi.org/10.1182/blood-2019-129087

Published: 2019

Journal Articles

Prophylactic or Preemptive Low-Dose Azacitidine (AZA) and Donor Lymphocyte Infusion (DLI) Prevent Disease Relapse Following Allogeneic Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Thierry Guillaume, MD PhD, Pierre Peterlin, Sylvain Thepot, MD, Amandine Le Bourgeois, MD, Alice Garnier, MD, Sylvie François, MD, Corentin Orvain, Yannick Le Bris, PharmD, Clémentine Fronteau, PharmD, Patrice Chevallier, MD

Blood (2019) 134 (Supplement_1): 4555.

https://doi.org/10.1182/blood-2019-123402

Published: 2019

Journal Articles

Real-World Effectiveness and Safety of Eltrombopag in Patients with Aplastic Anemia: A Chinese Nationwide Survey

Wenrui Yang, MD, Bing Han, MD PhD, Hong Chang, MD, Bingyi Wu, MD, Fankai Meng, Dexiang Ji, MD, Yingmei Li, MD, Zhengjin Zheng, MD, Yan Fei, Jianping Shen, MD, Ping Hu, MD, Jianxiang Wang, MD, Fengkui Zhang, MD

Blood (2019) 134 (Supplement_1): 5020.

https://doi.org/10.1182/blood-2019-126441

Published: 2019

Journal Articles

Effect and Safety of Ixazomib Plus Dexamethasone (ID) in Patients with Waldenstrom's Macroglobulinemia (WM): Real-World Evidences from a Single Center in China

Jiadai Xu, Zheng Wei, MD, Jing Li, MD, Jingli Zhuang, Lili Ji, Peng Liu, MD

Blood (2019) 134 (Supplement_1): 5265.

https://doi.org/10.1182/blood-2019-128816

Published: 2019

Journal Articles

Treatment of Delayed Hemolytic Transfusion Reactions in Sickle Cell Disease Patients By an Anti-C5 Antibody

Blood (2019) 134 (Supplement_1): 2458.

https://doi.org/10.1182/blood-2019-127176

Published: 2019

Journal Articles

Outcomes of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Included in Phase I Clinical Trials

Marion Brault, Maxime Annereau, PharmD, Alina Danu, MD, Julien Lazarovici, MD, Claude Chahine, MD, Andrea Varga, Capucine Baldini, Stéphane Champiat, Malik Berhoune, Christophe Massard, François Lemare, Vincent Ribrag, MD, Jean-Marie Michot, MD

Blood (2018) 132 (Supplement 1): 2992.

https://doi.org/10.1182/blood-2018-99-112919

Published: 2018

Journal Articles

Multicentric, Retrospective Study of Extracorporeal Photopheresis, Off-Line System, in Corticosteroid Refractory Acute and Chronic Graft-Versus-Host Disease

Gillen Oarbeascoa, MD, Maria Luisa Lozano, MD PhD, Luisa Maria Guerra, MD, Cristina Amunarriz, MD, Nuria Revilla, MD, Iniesta Pastora, MD, Cynthia Acosta Fleitas, MD, Jose Luis Arroyo, MD, Eva Martinez Revuelta, MD, Andrea Galego, MD, Dolores Hernandez-Maraver, PhD, Mi Kwon, Jose Luis Díez-Martín, MD PhD, Aurora Viejo, MD, Jose Maria Garcia-Gala, MD, Concepcion Andon Saavedra, Cristina Pascual, MD PhD, (GEA) Grupo Español de Aferesis

Blood (2018) 132 (Supplement 1): 3405.

https://doi.org/10.1182/blood-2018-99-118608

Published: 2018

Journal Articles

Successful of Chemo-Free Treatment with Dasatinib and Blinatumomab in a Pediatric EBF1-PDGFRβ Positive Acute Lymphoblastic Leukemia

Fara Petruzziello, MD, Giovanna Giagnuolo, MD, Giovanni Cazzaniga, PhD, Giuliana Beneduce, MD, Franco Locatelli, Pio Stellato, MD, Grazia Fazio, PhD, Giuseppe Mirabelli, PhD, Giuseppe Menna, MD, Rosanna Parasole, MD

Blood (2018) 132 (Supplement 1): 5213.

https://doi.org/10.1182/blood-2018-99-113829

Published: 2018

Journal Articles

Hepatitis B Virus Associated B-Cell Non-Hodgkin Lymphoma in Non-Endemic Areas

Marine Lemaitre, Pauline Brice, MD, Marco Frigeni, MD, Catherine Thieblemont, MD, Luca Arcaini, MD, Caroline Besson, MD PhD

Blood (2018) 132 (Supplement 1): 4228.

https://doi.org/10.1182/blood-2018-99-120349

Published: 2018

Journal Articles

Safety and Efficacy of Venetoclax in Relapsed Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Ceren Durer, MD, Seren Durer, MD, Awais Ijaz, MD, Ahmad Kamal, MD, Muhammad Abu Zar, MD, Abdul Rafae, MD, Mustafa Nadeem Malik, MD, Ali Younas Khan, MD, Muhammad Usman, MD, Insija Ilyas Selene, MBBS, Muhammad Junaid Tariq, MD, Muhammad Asad Fraz, MD, Jemin Aby Jose, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5625.

https://doi.org/10.1182/blood-2018-99-109925

Published: 2018

Journal Articles

Post-Transplantation Cyclophosphamide Versus Low Doses ATG Fresenius As Part of Two Immunosuppression Regimens for Graft Versus Host Disease Prophylaxis: Low Severe Graft Versus Host Disease (GVHD) Incidence and y Similar Gvhd-Free and Relapse-Free Survival (GRFS)

Cristina Fernández Martínez, Arancha Bermúdez, MD, Sara García Ávila, MD, Borja San Pedro, Almudena Cabero Martínez, MD, Lucrecia Yáñez, MD PhD, Mónica López Duarte, Mercedes Colorado, MD, Sonia González de Villambrosia, MD, Joan Manuel Mora, MD, Yolanda Gonzalez Romero, MD, David Gomez, MD, Sara Fenandez Luis, MD, Irati Ormazabal, MD, Andrés Insunza, Iñigo Romon, MD PhD, Jose Luis Arroyo, MD, Eulogio Conde, MD PhD, Carlos Richard, MD

Blood (2018) 132 (Supplement 1): 5716.

https://doi.org/10.1182/blood-2018-99-114124

Published: 2018

Journal Articles

CAN WE Predict Risk Factors of Venous Thromboembolism Among Cancer Inpatients?

Shiva Shrotriya, MD MPH, Prajwal Dhakal, MBBS, Mukta Sharma, MBBS, Joseph Gardiner, Anas Al-Janadi, MD, Alex Lupi, Ahmad Delshad, Supratik Rayamajhi, MD

Blood (2018) 132 (Supplement 1): 5871.

https://doi.org/10.1182/blood-2018-99-119698

Published: 2018

Journal Articles

Health Utility Analyses in AL Amyloidosis — Existing Mapping Algorithms May be Inadequate

Kristen L. McCausland, PhD MPH, Jakob Bjorner, PhD MD, Tiffany P. Quock, PhD MS, Spencer D Guthrie, MBA, Michelle K White, PhD, Martha S Bayliss, MSc

Blood (2017) 130 (Supplement 1): 3420.

https://doi.org/10.1182/blood.V130.Suppl_1.3420.3420

Published: 2017

Journal Articles

Effect of Autologous Hematopoietic Stem Cell Transplant (aHSCT) on the Development of Second Primary Malignancies (SPM) in Multiple Myeloma Patients

Aaron Seth Rosenberg, MD, Ann M Brunson, MS, Joseph M Tuscano, MD, Brian A Jonas, MD PhD, Mehrdad Abedi, MD, Ted Wun, MD FACP, FRCPA, Theresa H.M. Keegan, PhD MS

Blood (2017) 130 (Supplement 1): 332.

https://doi.org/10.1182/blood.V130.Suppl_1.332.332

Published: 2017

Journal Articles

Incidence of Secondary Malignancies in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in the Era of Tyrosine Kinase Inhibitors (TKI)

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Susan M. O'Brien, MD, Farhad Ravandi, MBBS, Marina Konopleva, MD PhD, Gautam Borthakur, MD, Guillermo Garcia-Manero, MD, William G Wierda, MD PhD, Naval Daver, MD, Alessandra Ferrajoli, MD, Koichi Takahashi, MD, Preetesh Jain, MBBS,MDDM,PhD, Mary B. Rios, RN, Sherry Pierce, BSN, BA, Elias J. Jabbour, MD, Jorge E. Cortes, MD

Blood (2017) 130 (Supplement 1): 1609.

https://doi.org/10.1182/blood.V130.Suppl_1.1609.1609

Published: 2017

Journal Articles

Hepatic Complications in Children with Sickle Cell Anemia Are Rare but Potentially Lethal

Mariane De Montalembert, MD PhD, Slimane Allali, MD, Laurent Dupic, MD, Cecile Dumesnil, MD, Annie Kamden, MD, Vincent Gajdos, MD PhD, Audrey Coilly, MD, Christophe Chardot, MD PhD, Martin Chalumeau, MD PhD, Valentine Brousse, MD, Florence Lacaille, MD

Blood (2017) 130 (Supplement 1): 4786.

https://doi.org/10.1182/blood.V130.Suppl_1.4786.4786

Published: 2017

Journal Articles

Phase II, Multicenter Trial, Exploring "Chemo-Sparing" Strategy Associating Obinutuzumab+Ibrutinib Followed By a MRD Driven Strategy, in Previously Untreated Symptomatic Medically Fit Chronic Lymphocytic Leukemia Patients (CLL): Preliminary Results of the Induction Phase of the Icll-07 Filo Study

Blood (2017) 130 (Supplement 1): 497.

https://doi.org/10.1182/blood.V130.Suppl_1.497.497

Published: 2017

Journal Articles

A Story about a Mother with Chronic Lymphocytic Leukemia after Chronic Phase of Chronic Myeloid Leukemia and Her Daughter with Chronic Myeloid Leukemia: Case Report and Literature Review

Qi Wei, MD, Yongqiang Wei, MD, Xiaolei Wei, Xiaofang LI, MD, Hui Liu, MD, Ru Feng, MD

Blood (2017) 130 (Supplement 1): 5265.

https://doi.org/10.1182/blood.V130.Suppl_1.5265.5265

Published: 2017

NARROW

Uncertainty in the R2 Calibration Curve for High Iron Concentration

Estimation of the Economic Burden Associated with Major Surgery Due to Von Willebrand Disease Based on Claims Data from the USA

Validation of the Ottawa Score in Cancer Patients with Venous Thromboembolism. the Predicare Cohort Study

Prophylactic or Preemptive Low-Dose Azacitidine (AZA) and Donor Lymphocyte Infusion (DLI) Prevent Disease Relapse Following Allogeneic Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Real-World Effectiveness and Safety of Eltrombopag in Patients with Aplastic Anemia: A Chinese Nationwide Survey

Effect and Safety of Ixazomib Plus Dexamethasone (ID) in Patients with Waldenstrom's Macroglobulinemia (WM): Real-World Evidences from a Single Center in China

Treatment of Delayed Hemolytic Transfusion Reactions in Sickle Cell Disease Patients By an Anti-C5 Antibody

Outcomes of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Included in Phase I Clinical Trials

Multicentric, Retrospective Study of Extracorporeal Photopheresis, Off-Line System, in Corticosteroid Refractory Acute and Chronic Graft-Versus-Host Disease

Successful of Chemo-Free Treatment with Dasatinib and Blinatumomab in a Pediatric EBF1-PDGFRβ Positive Acute Lymphoblastic Leukemia

Hepatitis B Virus Associated B-Cell Non-Hodgkin Lymphoma in Non-Endemic Areas

Safety and Efficacy of Venetoclax in Relapsed Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Post-Transplantation Cyclophosphamide Versus Low Doses ATG Fresenius As Part of Two Immunosuppression Regimens for Graft Versus Host Disease Prophylaxis: Low Severe Graft Versus Host Disease (GVHD) Incidence and y Similar Gvhd-Free and Relapse-Free Survival (GRFS)

CAN WE Predict Risk Factors of Venous Thromboembolism Among Cancer Inpatients?

Health Utility Analyses in AL Amyloidosis — Existing Mapping Algorithms May be Inadequate

Effect of Autologous Hematopoietic Stem Cell Transplant (aHSCT) on the Development of Second Primary Malignancies (SPM) in Multiple Myeloma Patients

Incidence of Secondary Malignancies in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in the Era of Tyrosine Kinase Inhibitors (TKI)

Hepatic Complications in Children with Sickle Cell Anemia Are Rare but Potentially Lethal

Phase II, Multicenter Trial, Exploring "Chemo-Sparing" Strategy Associating Obinutuzumab+Ibrutinib Followed By a MRD Driven Strategy, in Previously Untreated Symptomatic Medically Fit Chronic Lymphocytic Leukemia Patients (CLL): Preliminary Results of the Induction Phase of the Icll-07 Filo Study

A Story about a Mother with Chronic Lymphocytic Leukemia after Chronic Phase of Chronic Myeloid Leukemia and Her Daughter with Chronic Myeloid Leukemia: Case Report and Literature Review

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only